Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jason Fishman"'
Autor:
Lauralyn A McIntyre, David Moher, Dean A Fergusson, Katrina J Sullivan, Shirley H J Mei, Manoj Lalu, John Marshall, Malcolm Mcleod, Gilly Griffin, Jeremy Grimshaw, Alexis Turgeon, Marc T Avey, Michael A Rudnicki, Mazen Jazi, Jason Fishman, Duncan J Stewart, Canadian Critical Care Translational Biology Group
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147170 (2016)
The Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical condition that is associated with a 30-40% risk of death, and significant long term morbidity for those who survive. Mesenchymal stromal cells (MSC) have emerged as a potential
Externí odkaz:
https://doaj.org/article/8f1eef8c46e247249df355031cf2ada2
Autor:
Alexis F. Turgeon, Jason Fishman, Manoj M. Lalu, Malcolm Mcleod, Duncan J. Stewart, John Marshall, Michael A. Rudnicki, Dean Fergusson, Katrina J. Sullivan, Lauralyn McIntyre, Gilly Griffin, Mazen Jazi, Marc T. Avey, Shirley H. J. Mei, David Moher, Jeremy M. Grimshaw
Publikováno v:
PLoS ONE
Mcintyre, L A, Moher, D, Fergusson, D A, Sullivan, K J, Mei, S H J, Lalu, M, Marshall, J, MacLeod, M, Griffin, G, Grimshaw, J, Turgeon, A, Avey, M T, Rudnicki, M A, Jazi, M, Fishman, J & Stewart, D J 2016, ' Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review ', PLoS ONE, vol. 11, no. 1, pp. e0147170 . https://doi.org/10.1371/journal.pone.0147170
PLoS ONE, Vol 11, Iss 1, p e0147170 (2016)
Mcintyre, L A, Moher, D, Fergusson, D A, Sullivan, K J, Mei, S H J, Lalu, M, Marshall, J, MacLeod, M, Griffin, G, Grimshaw, J, Turgeon, A, Avey, M T, Rudnicki, M A, Jazi, M, Fishman, J & Stewart, D J 2016, ' Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review ', PLoS ONE, vol. 11, no. 1, pp. e0147170 . https://doi.org/10.1371/journal.pone.0147170
PLoS ONE, Vol 11, Iss 1, p e0147170 (2016)
The Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical condition that is associated with a 30–40% risk of death, and significant long term morbidity for those who survive. Mesenchymal stromal cells (MSC) have emerged as a potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::056d4135cd58bb6c1d6dd29583973b41
https://pubmed.ncbi.nlm.nih.gov/26821255
https://pubmed.ncbi.nlm.nih.gov/26821255
Autor:
Michael A. Rudnicki, Jason Fishman, John Marshall, Malcolm R. Macleod, Alexis F. Turgeon, Duncan J. Stewart, Kavita Singh, Becky Skidmore, Gilly Griffin, Lauralyn McIntyre, Manoj M. Lalu, David Moher, Dean Fergusson, Jeremy M. Grimshaw, Shirley H. J. Mei, Marc T. Avey
Publikováno v:
Systematic Reviews
Background: Acute respiratory distress syndrome (ARDS) in humans is caused by an unchecked proinflammatory response that results in diffuse and severe lung injury, and it is associated with a mortality rate of 35 to 45%. Mesenchymal stromal cells (MS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4912798d8590a40f3b1d9ed0655ec34c